HIF1A and pancreatic neoplasm: An effective strategy for treatment of solid tumours, therefore, indicates a possible addition of HIF‐1α inhibitor to iron chelation therapy, as reported in one of the studies exploiting a combination of DFO and HIF‐1α inhibitor (lificiguat/YC1) exhibiting a synergistic antitumour effect on pancreatic tumours in vitro and in xenograft mice models.158